EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
-5.42%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$319M
AUM Growth
+$319M
(-8.8%)
Cap. Flow
+$2.02M
Cap. Flow
% of AUM
0.63%
Top 10 Holdings %
Top 10 Hldgs %
63.37%
Holding
71
New
10
Increased
20
Reduced
18
Closed
16
Top Buys
| 1 |
The Ensign Group
ENSG
|
$13.3M |
| 2 |
GSK
GSK
|
$12.5M |
| 3 |
Ascendis Pharma
ASND
|
$9.63M |
| 4 |
Envista
NVST
|
$8.87M |
| 5 |
DexCom
DXCM
|
$6.65M |
Top Sells
| 1 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$17.6M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$9.61M |
| 3 |
RDUS
Radius Health, Inc.
RDUS
|
$9.42M |
| 4 |
eHealth
EHTH
|
$9.09M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
$5.37M |
Sector Composition
| 1 | Healthcare | 87.73% |
| 2 | Real Estate | 4.64% |
| 3 | Industrials | 2.03% |
| 4 | Communication Services | 1.05% |
| 5 | Financials | 0.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
GSK
GSK
$79.9B
| $42.3M | 13.13% | 983,085 +289,400 | +42% | +$12.5M |
|
|
2
The Ensign Group
ENSG
$9.91B
| $27.8M | 8.64% | 586,674 +281,191 | +92% | +$13.3M |
|
3
Danaher
DHR
$147B
| $25.8M | 8.02% | 178,704 +33,600 | +23% | +$4.86M |
|
|
ZGNX
4
DELISTED
Zogenix, Inc.
ZGNX
| $25.8M | 8% | 643,818 +107,024 | +20% | +$4.29M |
|
|
5
Ascendis Pharma
ASND
$11.8B
| $22.8M | 7.06% | 236,392 +99,995 | +73% | +$9.63M |
|
|
AMRN
6
Amarin Corp
AMRN
$311M
| $20.2M | 6.25% | 1,329,695 -228,370 | -15% | -$3.46M |
|
7
Sanofi
SNY
$121B
| $11.1M | 3.45% | 240,000 -26,062 | -10% | -$1.21M |
|
|
RDUS
8
DELISTED
Radius Health, Inc.
RDUS
| $8.88M | 2.75% | 344,698 -365,819 | -51% | -$9.42M |
|
|
9
Envista
NVST
$3.52B
| $8.87M | 2.75% | +318,000 | New | +$8.87M |
|
10
Vertex Pharmaceuticals
VRTX
$100B
| $8.63M | 2.68% | 50,909 -6,940 | -12% | -$1.18M |
|
11
Illumina
ILMN
$15.8B
| $8.14M | 2.52% | 26,750 +8,460 | +46% | +$2.57M |
|
12
Alnylam Pharmaceuticals
ALNY
$58.5B
| $7.4M | 2.3% | 92,040 +4,900 | +6% | +$394K |
|
|
BOLD
13
DELISTED
Audentes Therapeutics, Inc
BOLD
| $7.13M | 2.21% | 253,726 +94,200 | +59% | +$2.65M |
|
|
14
DexCom
DXCM
$29.5B
| $6.65M | 2.06% | +44,550 | New | +$6.65M |
|
|
RCM
15
DELISTED
R1 RCM Inc. Common Stock
RCM
| $6.48M | 2.01% | 725,972 -1,973,187 | -73% | -$17.6M |
|
|
ABMD
16
DELISTED
Abiomed Inc
ABMD
| $5.33M | 1.65% | +29,950 | New | +$5.33M |
|
17
Omega Healthcare
OHI
$12.6B
| $4.45M | 1.38% | 106,500 +65,100 | +157% | +$2.72M |
|
18
TG Therapeutics
TGTX
$4.65B
| $4.34M | 1.35% | 773,501 -110,000 | -12% | -$618K |
|
|
OXFD
19
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $4.26M | 1.32% | +256,000 | New | +$4.26M |
|
|
TLGT
20
DELISTED
Teligent, Inc
TLGT
| $4.2M | 1.3% | 4,424,222 +1,839,339 | +71% | +$1.75M |
|
21
argenx
ARGX
$43.6B
| $4.1M | 1.27% | 36,004 -12,260 | -25% | -$1.4M |
|
|
LTC
22
LTC Properties
LTC
$1.68B
| $3.55M | 1.1% | 69,327 +36,300 | +110% | +$1.86M |
|
23
Sabra Healthcare REIT
SBRA
$4.58B
| $3.54M | 1.1% | 154,100 +75,500 | +96% | +$1.73M |
|
|
MODN
24
DELISTED
MODEL N, INC.
MODN
| $3.35M | 1.04% | +120,695 | New | +$3.35M |
|
25
CareTrust REIT
CTRE
$7.66B
| $3.26M | 1.01% | 137,464 +75,000 | +120% | +$1.78M |
|